KIORA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
KIORA PHARMACEUTICALS, INC. (KPRX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $0 for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-04
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$11.00K.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $149.75K.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$20.00K.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-08-04 | -$11.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-05-05 | -$11.00K derived: sum of 3 quarters · filed 2017-05-05 | -$26.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$11.00K derived: sum of 2 quarters · filed 2017-02-23 | -$26.00K derived: sum of 3 quarters · filed 2017-08-04 | $149.75K 10-K · filed 2017-02-23 |
| 2016-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$26.00K derived: sum of 2 quarters · filed 2017-08-04 | $149.75K 10-Q · filed 2016-11-01 | $149.75K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $160.75K 10-Q · filed 2017-08-04 | $160.75K derived: sum of 3 quarters · filed 2017-08-04 | $160.75K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $175.75K 10-Q · filed 2017-05-05 | $175.75K derived: sum of 2 quarters · filed 2017-05-05 | $175.75K derived: sum of 3 quarters · filed 2017-05-05 | $175.75K derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | -$20.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | -$20.00K 10-Q · filed 2016-11-01 | -$20.00K derived: sum of 4 quarters · filed 2016-11-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$20.00K 10-Q · filed 2016-08-10 | -$20.00K derived: sum of 3 quarters · filed 2016-08-10 | -$20.00K derived: sum of 4 quarters · filed 2016-08-10 |
| 2015-03-31 | -$20.00K 10-Q · filed 2016-05-13 | -$20.00K derived: sum of 2 quarters · filed 2016-05-13 | -$20.00K derived: sum of 3 quarters · filed 2016-05-13 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |